Published in N Engl J Med on September 22, 1994
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation (2009) 1.76
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood (2011) 1.61
Kidney transplant candidates' views of the transplant allocation system. J Gen Intern Med (1997) 0.93
Using a standardized donor ratio to assess the performance of organ procurement organizations. Health Serv Res (2002) 0.90
HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation (1997) 0.89
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79
Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors. Transplantation (2011) 0.78
Accepting a donor kidney: an evaluation of patients' and transplant surgeons' priorities. Clin Transplant (2010) 0.78
Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex) (1998) 0.76
HLA matching in renal transplantation. N Engl J Med (1995) 0.75
Transplant genetics and genomics. Nat Rev Genet (2017) 0.75
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Hospital and patient characteristics associated with death after surgery. A study of adverse occurrence and failure to rescue. Med Care (1992) 5.33
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Hospital characteristics and mortality rates. N Engl J Med (1989) 4.97
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA (1992) 4.36
A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med (1992) 4.33
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10
Effectiveness in health care. An initiative to evaluate and improve medical practice. N Engl J Med (1988) 3.09
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis (1990) 2.91
Median sensory distal amplitude and latency: comparisons between nonexposed managerial/professional employees and industrial workers. Am J Ind Med (1993) 2.87
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int (2006) 2.18
Salt extraction of soluble HL-A antigens. Science (1971) 2.18
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation. N Engl J Med (1983) 2.15
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Obstetrics and malpractice. Evidence on the performance of a selective no-fault system. JAMA (1991) 1.98
Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol (1999) 1.95
Undertreatment of glaucoma among black Americans. N Engl J Med (1991) 1.93
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. Arch Ophthalmol (1991) 1.90
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant (2008) 1.88
Heats of the helix-coil transitions of the poly A-poly U complexes. Biopolymers (1968) 1.84
Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (1985) 1.83
Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care (1999) 1.82
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve (1992) 1.80
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Transplantation antigens. Adv Immunol (1970) 1.70
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Using clinical variables to estimate the risk of patient mortality. Med Care (1991) 1.65
C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. J Immunol (1972) 1.64
Use of community versus individual socioeconomic data in predicting variation in hospital use. Health Serv Res (1998) 1.64
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
The effect of bystander CPR on survival of out-of-hospital cardiac arrest victims. Am Heart J (1985) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
The role of monocytes in serum sickness nephritis. J Exp Med (1979) 1.55
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
En bloc transplantation of kidneys from pediatric donors. J Urol (1996) 1.51